Centessa Pharmaceuticals plc
CNTA
$39.76
$0.060.15%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -250.64M | -197.53M | -242.70M | -230.37M | -223.85M |
| Total Depreciation and Amortization | 343.00K | 321.00K | 310.00K | 309.00K | 319.00K |
| Total Amortization of Deferred Charges | 1.79M | 1.76M | 1.48M | 1.21M | 912.00K |
| Total Other Non-Cash Items | 37.08M | 31.67M | 66.18M | 67.75M | 67.70M |
| Change in Net Operating Assets | 2.64M | -30.03M | -6.07M | 17.22M | -7.10M |
| Cash from Operations | -208.80M | -193.82M | -180.81M | -143.89M | -162.02M |
| Capital Expenditure | -371.00K | -371.00K | -360.00K | -160.00K | -34.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -153.07M | -418.16M | -175.04M | -192.22M | -207.85M |
| Cash from Investing | -153.44M | -418.53M | -175.40M | -192.38M | -207.88M |
| Total Debt Issued | -- | -- | 109.34M | 109.34M | 109.34M |
| Total Debt Repaid | -- | -- | -110.10M | -110.10M | -110.10M |
| Issuance of Common Stock | 322.97M | 296.72M | 18.45M | 261.84M | 368.21M |
| Repurchase of Common Stock | -8.45M | -9.18M | -10.59M | -11.44M | -9.71M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 4.39M | 3.99M | 3.99M | 3.99M | -396.00K |
| Cash from Financing | 318.91M | 291.53M | 11.09M | 253.64M | 357.35M |
| Foreign Exchange rate Adjustments | 1.25M | -448.00K | 901.00K | -502.00K | -509.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -42.07M | -321.27M | -344.22M | -83.13M | -13.06M |